299 related articles for article (PubMed ID: 28502575)
1. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
Watson M; Benard V; King J; Crawford A; Saraiya M
Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
[TBL] [Abstract][Full Text] [Related]
2. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
4. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
5. Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality.
Saraiya M; Kwan A; Cooper CP
Prev Med; 2018 Mar; 108():111-114. PubMed ID: 29277414
[TBL] [Abstract][Full Text] [Related]
6. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
Eltoum IA; Roberson J
Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
[TBL] [Abstract][Full Text] [Related]
7. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends Survey.
Ashok M; Berkowitz Z; Hawkins NA; Tangka F; Saraiya M
J Womens Health (Larchmt); 2012 Jul; 21(7):705-12. PubMed ID: 22480224
[TBL] [Abstract][Full Text] [Related]
8. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
9. A model to evaluate the costs and clinical effectiveness of human papilloma virus screening compared with annual papanicolaou cytology in Germany.
Petry KU; Barth C; Wasem J; Neumann A
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():132-139. PubMed ID: 28363186
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer Screening Among Homeless Women of New York City Shelters.
Asgary R; Alcabes A; Feldman R; Garland V; Naderi R; Ogedegbe G; Sckell B
Matern Child Health J; 2016 Jun; 20(6):1143-50. PubMed ID: 26649876
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
12. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
Malo TL; Perkins RB; Lee JH; Vadaparampil ST
Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA.
Reiter PL; McRee AL
J Fam Plann Reprod Health Care; 2015 Oct; 41(4):259-64. PubMed ID: 25385868
[TBL] [Abstract][Full Text] [Related]
14. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
[TBL] [Abstract][Full Text] [Related]
15. Differences in cervical cancer screening and follow-up for black and white women in the United States.
Ford S; Tarraf W; Williams KP; Roman LA; Leach R
Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
[TBL] [Abstract][Full Text] [Related]
16. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
Guo F; Hirth JM; Berenson AB
Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
[TBL] [Abstract][Full Text] [Related]
19. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening among young adult women in the United States.
Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
